Cholankeril G - Search Results

1

Association between Body Fat Distribution and Nonalcoholic Fatty Liver Disease/Fibrosis Based on Race/Ethnicity.

Kim D, Cholankeril G, Ahmed A. Kim D, et al. Among authors: cholankeril g. J Obes Metab Syndr. 2024 Oct 21. doi: 10.7570/jomes24005. Online ahead of print. J Obes Metab Syndr. 2024. PMID: 39428122 Free article.

2

Beyond the baseline: Longitudinal surveillance with non-invasive tests for fibrosis in MASLD.

Tran VV, Kanwal F, Cholankeril G. Tran VV, et al. Among authors: cholankeril g. Hepatology. 2024 Sep 23. doi: 10.1097/HEP.0000000000001103. Online ahead of print. Hepatology. 2024. PMID: 39312505 No abstract available.

3

GLP-1 Receptor Agonists and Risk for Cirrhosis and Related Complications in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease.

Kanwal F, Kramer JR, Li L, Yang YX, Cao Y, Yu X, Samuel R, Ali B, Desiderio R, Cholankeril G, Bajaj M, El-Serag HB, Asch SM. Kanwal F, et al. Among authors: cholankeril g. JAMA Intern Med. 2024 Nov 1;184(11):1314-1323. doi: 10.1001/jamainternmed.2024.4661. JAMA Intern Med. 2024. PMID: 39283612 Free PMC article.

4

Leukocyte telomere shortening in metabolic dysfunction-associated steatotic liver disease and all-cause/cause-specific mortality.

Kim D, Danpanichkul P, Wijarnpreecha K, Cholankeril G, Ahmed A. Kim D, et al. Among authors: cholankeril g. Clin Mol Hepatol. 2024 Oct;30(4):982-986. doi: 10.3350/cmh.2024.0691. Epub 2024 Aug 27. Clin Mol Hepatol. 2024. PMID: 39188229 Free PMC article. No abstract available.

5

Contemporary awareness of nonalcoholic fatty liver disease and viral hepatitis based on the stage.

Kim D, Manikat R, Wijarnpreecha K, Cholankeril G, Ahmed A. Kim D, et al. Among authors: cholankeril g. Am J Med Sci. 2024 Dec;368(6):685-687. doi: 10.1016/j.amjms.2024.08.014. Epub 2024 Aug 17. Am J Med Sci. 2024. PMID: 39159751 No abstract available.

6

Unseen foe: The financial toxicity of liver transplantation.

Cholankeril G, Kanwal F. Cholankeril G, et al. Liver Transpl. 2024 Sep 1;30(9):873-874. doi: 10.1097/LVT.0000000000000406. Epub 2024 May 21. Liver Transpl. 2024. PMID: 39159308 No abstract available.

7

Reply to: "Transitioning FIB-4 score: From fibrosis screening tool to key biomarker for clinical endpoints".

Cholankeril G, Kramer JR, Yu X, Kanwal F. Cholankeril G, et al. J Hepatol. 2024 Nov;81(5):e230-e231. doi: 10.1016/j.jhep.2024.07.012. Epub 2024 Jul 20. J Hepatol. 2024. PMID: 39038548 No abstract available.

8

Burden of mortality from hepatocellular carcinoma and biliary tract cancers by race and ethnicity and sex in US, 2018-2023.

Kim D, Manikat R, Wijarnpreecha K, Cholankeril G, Ahmed A. Kim D, et al. Among authors: cholankeril g. Clin Mol Hepatol. 2024 Oct;30(4):756-770. doi: 10.3350/cmh.2024.0318. Epub 2024 Jun 24. Clin Mol Hepatol. 2024. PMID: 38910110 Free PMC article.

9

Estimated pulse wave velocity in metabolic dysfunction-associated steatotic liver disease and all-cause/cause-specific mortality.

Kim D, Manikat R, Wijarnpreecha K, Cholankeril G, Ahmed A. Kim D, et al. Among authors: cholankeril g. J Gastroenterol Hepatol. 2024 Sep;39(9):1950-1956. doi: 10.1111/jgh.16608. Epub 2024 May 13. J Gastroenterol Hepatol. 2024. PMID: 38740513

10

Steatotic liver disease-associated all-cause/cause-specific mortality in the United States.

Kim D, Wijarnpreecha K, Cholankeril G, Ahmed A. Kim D, et al. Among authors: cholankeril g. Aliment Pharmacol Ther. 2024 Jul;60(1):33-42. doi: 10.1111/apt.18011. Epub 2024 Apr 22. Aliment Pharmacol Ther. 2024. PMID: 38649335

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

169 results

Search Page

Filters